A randomized controlled trial to evaluate the effectiveness of capecitabine as a postoperative adjuvant regimen in inhibiting the recurrence of intrahepatic cholangiocarcinoma after curative resection
Latest Information Update: 23 Jun 2016
At a glance
- Drugs Capecitabine (Primary)
- Indications Cholangiocarcinoma
- Focus Therapeutic Use
- 18 Jun 2013 New trial record